Homepage - Unitaid
- ️Thu Feb 13 2025
Unitaid remains committed to equitable access to critical health innovations
06 February 2025 | Statement
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
28 November 2024 | News
Unitaid to double its investment in maternal and newborn health with call for proposals that address preeclampsia and anemia
21 November 2024 | News
Saving lives faster
We believe that everyone, no matter where they live, should be able to benefit from the best health products and interventions. But every year, millions of people in low- and middle-income countries fall ill and sometimes die from preventable, treatable diseases because the care they need is unavailable.
Unitaid was created to address this inequality. We save lives by making health products accessible, available and affordable for people who need them most – fast.
300 m people
Every year, 300 million people use our health products
100 + tools
Since 2006 we have introduced 100+ groundbreaking tools
3 x faster
Our approach helps reach global health targets three years faster
US$ 8 bn saved
By 2030 our work is estimated to generate US$8 billion in savings
Our areas of focus
HIV & coinfections
Incredible progress has been made in the fight against HIV since the peak of the epidemic. But progress is not reaching all groups equally, as key populations, adolescent girls and young women, and children are shouldering a disproportionate burden.
Meanwhile, we must keep up the momentum to tackle new challenges like drug-resistance that threaten hard-won gains.
Tuberculosis
Despite our best efforts, new tuberculosis (TB) infections are on the rise and drug-resistance is a threat to health security. Children are at the heart of this crisis, facing the lowest rates of detection and some of the highest rates of death from TB.
New tests, medicines, and preventive therapies can turn the tide, but their impact will be limited if we do not urgently ensure everyone can benefit.
Malaria
Over the past 20 years, remarkable progress has been achieved in the fight against malaria. But this progress is under threat.
Funding has stalled, vital tools are becoming less effective, shifting climate patterns are changing mosquito behavior and expanding malaria zones, and the COVD-19 pandemic has created new setbacks.
Women’s & children’s health
A historic one-size-fits-all approach, largely based on the needs and physiologies of men, has contributed to countless gaps in care – creating blind spots in medical research, inattention to the unique needs and conditions that primarily affect women or children and widening disparities.
Correcting for these inequities delivers massive positive returns that ripple through societies – reducing poverty, advancing equality, and building more prosperous communities.
Global health emergencies
Governments and health systems must urgently strengthen their approach to pandemic prevention, preparedness and response if we are to avoid the catastrophic impacts of another crisis like the COVID-19 pandemic.
Our ongoing work supports countries to address today’s health challenges while also building the capacity to respond to future pandemics.
Oxygen
Though medical oxygen is a lifesaving medicine with no substitute, less than 50% of health facilities in low- and middle-income countries have uninterrupted access.
Equitable, sustainable access to medical oxygen is key to improving maternal and child health, strengthening primary health care in support of universal health coverage, and ensuring health systems are better prepared for the next global health emergency.
Climate & health
The WHO has called climate change “the single biggest health threat facing humanity.” Its impacts are jeopardizing progress in development, global health and poverty reduction, and creating new health risks that disproportionately affect the most vulnerable communities.
While the global health sector is racing to address the impacts of climate change on health, it also contributes 4.6% of the world’s carbon emissions.
Regional manufacturing
Although Africa shoulders 25% of the world’s disease burden – including major infectious diseases like HIV, TB and malaria – more than 95% of the active pharmaceutical ingredients and 70% of the pharmaceuticals consumed on the continent are imported.
This leaves countries vulnerable to price volatility, supply chain disruptions or unavailability of essential health products.
Cross-cutting priorities
Improving well-being and saving lives is achievable with the right kind of testing and treatment tools, new technologies, and ensuring equitable access to optimal care for all those who need it.
Cross-cutting priorities contribute to the fight against HIV, TB, and malaria, and also impact many more areas, including maternal health and future global health emergencies.
Feature stories
Calls for proposals
Your smart ideas can help tackle some of the greatest challenges facing global health today.